TFEB and breast carcinoma: For instance, TFEB reduced the sensitivity of LoVo and HeLa cells to doxorubicin by inducing activation of autophagy (Fang L. M. et al., 2017), and it reduced the apoptosis of breast cancer cells in response to doxorubicin by repairing DNA damage (Slade et al., 2020).